July 1, 2022
Mesh Bio, MultiOmic partner to develop chronic metabolic disease medicines
Digital health start-up Mesh Bio has collaborated with drug discovery company MultiOmic Health to use artificial intelligence (AI) for developing precision medicines and diagnostics for chronic metabolic disease.